You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 10, October 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Extract
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neonatology and Infant Care
 •Alert me on articles by topic

Radiological Case of the Month

David B. Thomas, MD; Angela K. Sidler, MD; Butch M. Huston, MD
From the Departments of Pathology (Drs Thomas and Huston) and Pediatrics (Dr Sidler), University of North Carolina, Chapel Hill.

Arch Pediatr Adolesc Med. 1998;152:1029-1030.

AN 8-DAY-OLD male infant weighing 2892 g was referred to the hospital for evaluation of a chest wall mass. He had been delivered vaginally by vacuum extraction. The course of the pregnancy was unremarkable and the patient's mother received routine prenatal care.

On physical examination, the patient appeared well developed and was in no apparent distress. Vital signs were stable. A firm, immobile, nontender chest mass was located slightly to the left of the sternum. The mass measured 1.5 cm in diameter and projected 0.5 cm from the contour of the chest. Findings from the remainder of the examination were unremarkable.

Multiplanar imaging of the chest wall indicated a well-defined heterogeneous mass that appeared to grow from the intercostal muscles, invaded the intercostal muscles posteriorly, and displaced the pleura. The mass measured 1 x 2.5 x 2.5 cm in the anteroposterior, transverse, and cephalocaudal dimensions (Figure 1 and Figure 2). It did not involve the pericardium, but bony invasion of the ribs and sternum could not be completely excluded.


Figure 1.


Figure 2.

The next day, an incisional biopsy was performed. Histological study of the mass showed a predominant population of large polygonal cells and a smaller number of admixed multinucleate giant cells (Figure 3). Both the mononuclear and multinuclear cells had a moderate to large amount of lightly eosinophilic cytoplasm. The nuclei in the mononuclear and multinucleate cells were slightly enlarged and irregular, but significant hyperchromasia was not present and nucleoli were inconspicuous. The mitotic rate was low at fewer than 2 mitoses per 10 high-power fields. The lesion infiltrated skeletal muscle. Stains for fungi and mycobacteria were negative. The mononuclear and multinucleate cells were strongly positive on a vimentin stain. Actin, desmin, S100, factor VIII, and cytokeratin stains all were negative.


Figure 3.


Denouement and Discussion: Juvenile Xanthogranuloma

Figure 1. Sagittal T1 magnetic resonance imaging scan of the chest wall mass.

Figure 2. Axial T1 magnetic resonance imaging scan of the chest wall mass.

Figure 3. Histological section from biopsy specimen of the chest wall mass shows a predominant population of large polygonal cells and a smaller number of admixed multinucleate Touton giant cells (hematoxylin-eosin, original magnification x50).

Deep juvenile xanthogranuloma (JXG) is a rare fibrohistiocytic tumor and a less common form of xanthogranuloma (congenital xanthoma multiplex, nevoxanthoendothelioma), accounting for less than 5% of JXG. It occurs in newborns and infants, and is characterized by 1 or more cutaneous nodules, a self-limited course with spontaneous regression, and rare extracutaneous involvement. Neither the cutaneous nor the extracutaneous form of the disease is associated with underlying metabolic disease, lipid abnormality, or a familial incidence.1 Juvenile xanthogranuloma occurs in patients 0 to 5 years of age, and may also occur in adolescents and young adults.

Extracutaneous or deep JXG are reported in deep soft tissue and parenchymal organs. Expected sites of deep JXG include the eye, lung, epicardium, oral cavity, testes,2 central nervous system, liver/spleen, and muscle.3 The differential diagnosis of congenital, anterior chest wall tumors includes rhabdomyoblastoma, neuroblastoma, and primitive neuroectodermal tumor. Prognosis for deep JXG is excellent, as spontaneous regression does occur.4 A chromosomal analysis shows normal karyotype.5

Lesions can range in diameter from a few millimeters to several centimeters and are firm, well circumscribed, and vary from tan to yellow on the cut surface.3-7

Histological examination reveals sheets of well-differentiated histiocytes with little pleomorphism. The foamy cells have abundant cytoplasm and morphologically variable nuclei with finely dispersed chromatin. Multinucleated cells, including Touton giant cells, are typically present. Mixed inflammatory cell infiltrates may be present along the border of the lesion. Immunohistochemistry is characterized by the absence of 5-100 staining and variable presence of other histiocytic markers.7 The cortical thymocyte antigen, Cdla, is positive, suggesting a dermal "indeterminate" cell lineage.5 Ultrastructure examination shows histiocytes with irregular cell membrane and filiform cytoplasmic projections. Lipid bodies and myelin figures are present and Birbeck granules of Langerhans histiocytoses (histiocytosis X) are notably absent.

The pathogenesis of deep JXG is uncertain, and it is unresolved whether the lesion represents a true neoplasm or an unusual reaction. Both the clinical course of natural involution and the immunohistochemical profile lend support to the theory that JXG represents a benign histiocytic proliferation that is likely to be a reactive process.


AUTHOR INFORMATION

Accepted for publication July 30, 1997.

Reprints: Butch M. Huston, MD, University of North Carolina Hospitals, Department of Pathology, 422 Brinkhous-Bullitt Bldg, CB 7525, Chapel Hill, NC 27599-7525.


REFERENCES

1. Enzinger FM, Weiss SW. Benign fibrohistiocytic tumors. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St Louis, Mo: Mosby–Year Book Inc; 1995.
2. DeGraaf JH, Timens W, Tamminga RYJ, Molenaar WM. Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells. Hum Pathol. 1992;23:905-910. PUBMED
3. Freyer DR, Kennedy R, Bostrom BC, Kohut G, Dehner LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;12:227-237.
4. Janney CG, Hurt MA, Santa Cruz DJ. Deep juvenile xanthogranuloma: subcutaneous and intramuscular forms. Am J Surg Pathol. 1991;15:150-159. PUBMED
5. Isaacs H. Tumors. In: Gilbert-Barness E, ed. Potter's Pathology of the Fetus and Infant. St Louis, Mo: Mosby–Year Book Inc; 1997:1275.
6. Dehner LP, Kaye V. The skin. In: Stocker JT, Dehner LP, eds. Pediatric Pathology. Philadelphia, Pa: JB Lippincott; 1992:1165-1166.
7. Sangueza OP, Salmon JK, White CR Jr, Beckstead JH. Juvenile xanthogranuloma: a clinical, histopathologic and immunohistochemical study. J Cutan Pathol. 1995;22:327-335. PUBMED

SECTION EDITOR: BEVERLY P. WOOD, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.